08045804946
Send Inquiry
SAMLUTA 40MG CAPS
2600.0 INR/Vial
Product Details:
- Brand Name Samluta
- Life Span 24 months from manufacturing date
- Indication Renal cell carcinoma and gastrointestinal stromal tumor
- Origin of Medicine India
- Salt Composition Sunitinib Malate
- Pacakaging (Quantity Per Box) 28 capsules
- Packaging Type Box
- Click to View more
X
SAMLUTA 40MG CAPS Price And Quantity
- 1 Number
- 2600.0 INR/Vial
- Yes, prescription only
- Pink body/yellow cap
- 40mg per capsule
- Used for first-line treatment and after failure of imatinib therapy
- L01XE04
- Fatigue, hypertension, diarrhea, hand-foot syndrome, stomatitis
- Oral
- Hypersensitivity to sunitinib or any component
- 24 months
SAMLUTA 40MG CAPS Product Specifications
- Adults with renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST)
- Renal cell carcinoma and gastrointestinal stromal tumor
- Store below 30C, protect from light and moisture
- 24 months from manufacturing date
- Samluta
- Anti-cancer medication, Tyrosine Kinase Inhibitor
- As prescribed by the physician
- Adults
- 28 capsules
- 1 box
- Capsule
- Box
- Capsule
- India
- Allopathic
- Sunitinib Malate 40mg
- Swallow whole, do not crush or chew
- Sunitinib Malate
- Yes, prescription only
- Pink body/yellow cap
- 40mg per capsule
- Used for first-line treatment and after failure of imatinib therapy
- L01XE04
- Fatigue, hypertension, diarrhea, hand-foot syndrome, stomatitis
- Oral
- Hypersensitivity to sunitinib or any component
- 24 months
SAMLUTA 40MG CAPS Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Asia, Australia, Africa
- All India
Product Description
- Active Ingredient: Enzalutamide 40mg.
- Medical Class: Androgen receptor inhibitor/antiandrogen.
- Primary Use: Treatment of various stages of prostate cancer, including metastatic castration-resistant, non-metastatic castration-resistant, and metastatic hormone-sensitive prostate cancer. It is used in adult males, especially when the cancer no longer responds to standard hormone therapy or surgical interventions.
- Mechanism of Action: Most prostate cancers need testosterone to grow. Enzalutamide prevents testosterone from binding to cancer cells' androgen receptors, which slows the growth of the cancer and may cause tumors to shrink.
- Dosage: The typical daily dose is 160mg (four 40mg capsules), taken orally once a day with or without food, or as directed by a doctor.
- Important Precautions:
- It should be used under proper medical guidance and is available by prescription only.
- It is not recommended for women, especially during pregnancy or breastfeeding, due to the risk of harm to an unborn baby.
- Men using this medication must use effective contraception during treatment and for at least three months after the final dose.
- It may increase the risk of seizures, so patients with a history of seizures, brain injury, or stroke require extra caution.
- Regular monitoring of blood pressure, liver function, and blood cell count is essential during treatment.
Purpose and Indications
SAMLUTA 40MG CAPS is used primarily in adults for the first-line treatment of renal cell carcinoma (RCC) and for gastrointestinal stromal tumor (GIST) when previous therapies such as imatinib have not been effective. Its targeted action helps hinder tumor progression and is vital in specialized oncological care.
Dosage and Administration Instructions
The recommended dosage is as prescribed by a qualified healthcare professional. SAMLUTA capsules should be swallowed whole with water; do not crush or chew them. This oral medication is packaged in boxes containing 28 capsules, ensuring accurate dosing over the treatment period.
Key Safety Information and Side Effects
SAMLUTA is not suitable for those with hypersensitivity to sunitinib or its components. Common side effects include fatigue, high blood pressure, diarrhea, hand-foot syndrome, and mouth inflammation. Immediate medical attention may be required for severe reactions. Always consult your physician for guidance.
FAQ's of SAMLUTA 40MG CAPS:
Q: How should SAMLUTA 40MG CAPS be taken for optimal effectiveness?
A: SAMLUTA 40MG CAPS should be swallowed whole, not chewed or crushed, ideally with water and according to the schedule provided by your physician. Never change your dose or frequency without medical advice.Q: What cancers is SAMLUTA 40MG CAPS used to treat?
A: SAMLUTA is prescribed for adults with renal cell carcinoma (RCC) and gastrointestinal stromal tumor (GIST), particularly when first-line treatment with imatinib has failed or is not suitable.Q: When is SAMLUTA 40MG CAPS contraindicated?
A: SAMLUTA should not be used in patients with known hypersensitivity to sunitinib or any ingredient in the formulation. Consult your doctor if you have concerns about allergies.Q: Where should SAMLUTA 40MG CAPS be stored for maximum shelf life?
A: Store SAMLUTA below 30C, protected from light and moisture, to preserve its stability and effectiveness throughout the 24-month shelf life.Q: What side effects could occur when taking SAMLUTA 40MG CAPS?
A: Possible side effects include fatigue, hypertension, diarrhea, hand-foot syndrome, and mouth inflammation (stomatitis). Contact your healthcare provider if you experience severe or persistent symptoms.Q: How does SAMLUTA 40MG CAPS benefit adult patients with RCC or GIST?
A: By inhibiting specific enzymes essential for cancer cell growth, SAMLUTA helps slow tumor progression, providing a targeted therapeutic option for RCC and GIST cases unresponsive to other treatments.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
